About Earkart Limited
Earkart an Indian tech-driven hearing healthcare company dedicated to making advanced audiology services and hearing aids more accessible, affordable, and transparent. Listed on the BSE SME platform, it operates across India and neighboring countries, specializing in both manufacturing and distributing modern digital hearing solutions
Founded
2021
CEO
Rohit Misra
Employees
38
HQ
New Delhi, India
Finished Products
1Hearing Aids
₹33.95Cr2Other
₹4.99Cr3Hearing Aids -Traded
₹2.11Cr4Hearing Aids Parts & Accessori
₹1.34Cr5Conversion Charge
₹0.55Cr6Franchise Fees
₹0.12Cr7Audiometry Charge
₹0.04Cr1–7 of 8
Raw Materials
1Cost of Material Consumed
₹20.68Cr2Purchases of Stock in Trade
₹4.73CrAbout Earkart Limited
Earkart an Indian tech-driven hearing healthcare company dedicated to making advanced audiology services and hearing aids more accessible, affordable, and transparent. Listed on the BSE SME platform, it operates across India and neighboring countries, specializing in both manufacturing and distributing modern digital hearing solutions
Founded:2021
CEO:Rohit Misra
Employees:38
HQ:New Delhi, India
Finished Products
1Hearing Aids
₹33.95Cr2Other
₹4.99Cr3Hearing Aids -Traded
₹2.11Cr4Hearing Aids Parts & Accessori
₹1.34Cr5Conversion Charge
₹0.55Cr6Franchise Fees
₹0.12Cr7Audiometry Charge
₹0.04Cr1–7 of 8
Raw Materials
1Cost of Material Consumed
₹20.68Cr2Purchases of Stock in Trade
₹4.73CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹266
52W Low
₹104
Volume3.00K
Avg VolumeN/A
BetaN/A
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
N/A
Valuation
P/B Ratio
2.57x
Valuation
EPS
₹0.00
Valuation
Dividend Yield
0.00%
Valuation
ROE
7.67%
Profitability
ROCE
12.12%
Profitability
Revenue by Segment
Contribution & growth by business line
No segment revenue data available
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
100.0%
Domestic Sale99.6%
Exports0.4%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.00x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
14.2%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.